Could a single pill replace two for diabetes?
NCT ID NCT07412015
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study will test whether a new fixed-dose combination tablet containing Chiglitazar and Metformin works the same in the body as taking the two drugs separately. Twenty-four healthy adults will receive both versions under fed conditions, and researchers will measure drug levels in the blood. The goal is to see if the combo pill is a viable option for simplifying type 2 diabetes treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Chiglitazar/Metformin extended-release fixed dose combination tablets
- What this could lead to
- If successful, this could lead to a simpler once-daily pill for type 2 diabetes, making treatment easier for patients.
- What could go wrong
- This is a very early pilot study in only 24 healthy people, not patients. It only checks how the drug is processed in the body, not whether it works for diabetes. Results may not predict real-world benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM (TYPE 2 DIABETES MELLITUS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an Anti-Inflammatory diet tame type 2 diabetes?
- New diabetes combo pill aims to beat single drugs in major trial
- New combo therapy aims to improve diabetes management
- New triple therapy aims to protect kidneys in diabetes patients
- New combo diabetes pill tested in healthy volunteers
- New diabetes pill put to the test: does food change how it works?